These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35664052)

  • 1. Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: An observational study.
    McManus E; Meacock R; Parkinson B; Sutton M
    Lancet Reg Health Eur; 2022 Aug; 19():100420. PubMed ID: 35664052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation.
    Penn L; Rodrigues A; Haste A; Marques MM; Budig K; Sainsbury K; Bell R; Araújo-Soares V; White M; Summerbell C; Goyder E; Brennan A; Adamson AJ; Sniehotta FF
    BMJ Open; 2018 Feb; 8(2):e019467. PubMed ID: 29467134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholders' perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers.
    Rodrigues AM; Haste A; Penn L; Bell R; Summerbell C; White M; Adamson AJ; Sniehotta FF
    BMC Health Serv Res; 2020 Apr; 20(1):307. PubMed ID: 32293424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in England.
    Bower P; Soiland-Reyes C; Heller S; Wilson P; Cotterill S; French D; Sutton M
    Diabet Med; 2023 Nov; 40(11):e15209. PubMed ID: 37634235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience.
    Hawkes RE; Cameron E; Cotterill S; Bower P; French DP
    BMC Health Serv Res; 2020 Nov; 20(1):1098. PubMed ID: 33246460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of demographic, health and psychosocial factors on patient uptake of the English NHS diabetes prevention programme.
    Reeves D; Woodham AA; French D; Bower P; Holland F; Kontopantelis E; Cotterill S
    BMC Health Serv Res; 2023 Apr; 23(1):352. PubMed ID: 37041541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the NHS Diabetes Prevention Programme Intervention Delivered as Planned? An Observational Study of Fidelity of Intervention Delivery.
    French DP; Hawkes RE; Bower P; Cameron E
    Ann Behav Med; 2021 Oct; 55(11):1104-1115. PubMed ID: 33580647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.
    Mytton OT; Jackson C; Steinacher A; Goodman A; Langenberg C; Griffin S; Wareham N; Woodcock J
    PLoS Med; 2018 Mar; 15(3):e1002517. PubMed ID: 29509767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Early Use of the Nationally Implemented Healthier You National Health Service Digital Diabetes Prevention Programme: Mixed Methods Study.
    Ross J; Hawkes RE; Miles LM; Cotterill S; Bower P; Murray E
    J Med Internet Res; 2023 Aug; 25():e47436. PubMed ID: 37590056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The English national health service diabetes prevention programme (NHS DPP): A scoping review of existing evidence.
    Whelan M; Bell L
    Diabet Med; 2022 Jul; 39(7):e14855. PubMed ID: 35441747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the design of the NHS Diabetes Prevention Programme intervention have fidelity to the programme specification? A document analysis.
    Hawkes RE; Cameron E; Bower P; French DP
    Diabet Med; 2020 Aug; 37(8):1357-1366. PubMed ID: 31808578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of weight change between face-to-face and digital delivery of the English National Health service diabetes prevention programme: An exploratory non-inferiority study with imputation of plausible weight outcomes.
    Marsden AM; Hann M; Barron E; Ross J; Valabhji J; Murray E; Cotterill S
    Prev Med Rep; 2023 Apr; 32():102161. PubMed ID: 36926593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediabetes, participation in the English National Health Service Diabetes Prevention Programme, and associations with COVID-19-related mortality: A whole population study.
    Barron E; Sharp SJ; Khunti K; Bakhai C; Wareham NJ; Valabhji J
    Diabetes Res Clin Pract; 2024 Jun; 212():111692. PubMed ID: 38723673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative evaluation of the national rollout of a diabetes prevention programme in England.
    Brunton L; Soiland-Reyes C; Wilson P
    BMC Health Serv Res; 2023 Sep; 23(1):1043. PubMed ID: 37773125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of goal setting in the NHS England diabetes prevention programme.
    Hawkes RE; Warren L; Cameron E; French DP
    Psychol Health; 2022 Feb; 37(2):131-150. PubMed ID: 33517780
    [No Abstract]   [Full Text] [Related]  

  • 17. Could diabetes prevention programmes result in the widening of sociodemographic inequalities in type 2 diabetes? Comparison of survey and administrative data for England.
    Chatzi G; Whittaker W; Chandola T; Mason T; Soiland-Reyes C; Sutton M; Bower P
    J Epidemiol Community Health; 2023 Sep; 77(9):565-570. PubMed ID: 37353312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
    Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE
    Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.